Sandbox/table

The following table contains the main risk factors for CDI:^[1]^[2]^[3]^[2]^[2]

Alterations in the coagulation system
Consumption of clotting factors
Increased concentrations of fibrin degradation products
Disseminated intravascular coagulation

table

**Laboratory findings**
Test	Findings
White blood cells count	Leucopenia (1000 cells/μL) Lymphopenia Neutrophilia
Blood smear	Left shift Atypical lymphocytes
Liver function tests	Raised aspartate aminotransferase Raisedalanine aminotransferase Extended prothrombin time Extendedpartial thromboplastin time
Proteins	Hyperproteinemia
Urinalysis	Proteinuria

**Countries with a reported prevalence <15% of *H. pylori* resistance to clarithromycin**
Diagnostic test	North America	South America	Middle East	Far East
ELISA (serology) detects: Viral Antigen IgM and IgG antibody \| hol

^† There is a reported prevalence of 15% in the Northeast of the US.

↑ Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
↑ ^2.0 ^2.1 ^2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
↑ Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.